Xia Gong

2.1k total citations
44 papers, 1.8k citations indexed

About

Xia Gong is a scholar working on Pharmacology, Molecular Biology and Immunology. According to data from OpenAlex, Xia Gong has authored 44 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 11 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Xia Gong's work include Drug-Induced Hepatotoxicity and Protection (14 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pharmacological Effects of Natural Compounds (5 papers). Xia Gong is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (14 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pharmacological Effects of Natural Compounds (5 papers). Xia Gong collaborates with scholars based in China and United States. Xia Gong's co-authors include Jingyuan Wan, Ge Kuang, Hongzhong Li, Rong Jiang, Li Zhang, Zhuo Zhang, Xinru Yin, Hongyuan Li, Bin Wang and Su Min and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Free Radical Biology and Medicine and Frontiers in Immunology.

In The Last Decade

Xia Gong

44 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xia Gong China 29 667 456 299 274 254 44 1.8k
Hamid Mollazadeh Iran 26 663 1.0× 266 0.6× 362 1.2× 254 0.9× 153 0.6× 49 2.0k
Bidya Dhar Sahu India 26 745 1.1× 291 0.6× 203 0.7× 248 0.9× 127 0.5× 58 2.1k
Robert Domitrović Croatia 28 748 1.1× 686 1.5× 221 0.7× 298 1.1× 346 1.4× 54 2.5k
Jeng‐Shyan Deng Taiwan 26 840 1.3× 394 0.9× 204 0.7× 411 1.5× 141 0.6× 49 1.8k
Chien‐Chun Li Taiwan 22 853 1.3× 231 0.5× 352 1.2× 160 0.6× 181 0.7× 57 1.9k
Yanling Zhao China 22 848 1.3× 441 1.0× 274 0.9× 244 0.9× 292 1.1× 76 1.9k
Jing‐Hsien Chen Taiwan 24 703 1.1× 438 1.0× 366 1.2× 122 0.4× 150 0.6× 50 1.9k
Chunhua Ma China 28 1.2k 1.8× 339 0.7× 268 0.9× 264 1.0× 182 0.7× 56 2.3k
Yuchen Sheng China 25 776 1.2× 604 1.3× 193 0.6× 217 0.8× 267 1.1× 46 1.7k
Hui‐Hsuan Lin Taiwan 24 612 0.9× 448 1.0× 350 1.2× 113 0.4× 141 0.6× 44 1.7k

Countries citing papers authored by Xia Gong

Since Specialization
Citations

This map shows the geographic impact of Xia Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Gong more than expected).

Fields of papers citing papers by Xia Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Gong. The network helps show where Xia Gong may publish in the future.

Co-authorship network of co-authors of Xia Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Gong. A scholar is included among the top collaborators of Xia Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Gong. Xia Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tie, Hongtao, Ge Kuang, Xia Gong, et al.. (2024). LXA4 protected mice from renal ischemia/reperfusion injury by promoting IRG1/Nrf2 and IRAK-M-TRAF6 signal pathways. Clinical Immunology. 261. 110167–110167. 3 indexed citations
2.
3.
Xie, Yao, Leyi Wei, Yang Xiang, et al.. (2024). Ginkgolide C attenuated Western diet-induced non-alcoholic fatty liver disease via increasing AMPK activation. Inflammation. 48(2). 770–782. 4 indexed citations
4.
Zhang, Lidan, Ge Kuang, Xia Gong, et al.. (2024). Piperine attenuates hepatic ischemia/reperfusion injury via suppressing the TLR4 signaling cascade in mice. Transplant Immunology. 84. 102033–102033. 3 indexed citations
5.
Tong, Shiwen, Ge Kuang, Xia Gong, et al.. (2023). Sesamin Protects against APAP-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Inflammatory Response via Deactivation of HMGB1/TLR4/NFκB Signal in Mice. Journal of Immunology Research. 2023. 1–15. 9 indexed citations
6.
Guo, Peipei, Jun-Xia Yang, Xinru Yin, et al.. (2022). MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-κB Signaling in Mice. Mediators of Inflammation. 2022. 1–13. 8 indexed citations
7.
Liu, Jin, Xia Gong, Liangke Zhang, et al.. (2020). Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice. International Immunopharmacology. 80. 106208–106208. 51 indexed citations
8.
Yang, Sen, Ge Kuang, Liangke Zhang, et al.. (2020). Mangiferin Attenuates LPS/D-GalN-Induced Acute Liver Injury by Promoting HO-1 in Kupffer Cells. Frontiers in Immunology. 11. 285–285. 44 indexed citations
9.
Li, Jie, Lu Hu, Xia Gong, et al.. (2019). Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via β-catenin signaling. Life Sciences. 232. 116617–116617. 61 indexed citations
10.
11.
Zhang, Li, Li Ma, Rong Jiang, et al.. (2017). Glycyrrhetinic acid prevents acetaminophen-induced acute liver injury via the inhibition of CYP2E1 expression and HMGB1-TLR4 signal activation in mice. International Immunopharmacology. 50. 186–193. 57 indexed citations
12.
Lin, Dan, Ge Kuang, Jingyuan Wan, et al.. (2016). Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression. Oncology Reports. 37(2). 895–902. 99 indexed citations
13.
Gong, Xia. (2016). PROTECTIVE EFFECT OF Ailanthus excelsa ROXB IN MYOCARDIAL INFARCTION POST MESENCHYMAL STEM CELL TRANSPLANTATION: STUDY IN CHRONIC ISCHEMIC RAT MODEL. African Journal of Traditional Complementary and Alternative Medicines. 13(6). 155–162. 1 indexed citations
14.
Ma, Li, et al.. (2015). Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice. Biochemical and Biophysical Research Communications. 461(2). 230–236. 30 indexed citations
15.
Wang, Bin, et al.. (2014). Mangiferin attenuates renal ischemia-reperfusion injury by inhibiting inflammation and inducing adenosine production. International Immunopharmacology. 25(1). 148–154. 27 indexed citations
16.
Yin, Xinru, Xia Gong, Rong Jiang, et al.. (2014). Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice. International Immunopharmacology. 23(1). 66–72. 28 indexed citations
17.
Gong, Xia, Li Zhang, Rong Jiang, et al.. (2012). Anti-inflammatory effects of mangiferin on sepsis-induced lung injury in mice via up-regulation of heme oxygenase-1. The Journal of Nutritional Biochemistry. 24(6). 1173–1181. 74 indexed citations
18.
Wang, Bin, Xia Gong, Jingyuan Wan, et al.. (2011). Resolvin D1 protects mice from LPS-induced acute lung injury. Pulmonary Pharmacology & Therapeutics. 24(4). 434–441. 153 indexed citations
19.
Gong, Xia, Fuling Luo, Li Zhang, et al.. (2009). Tetrandrine attenuates lipopolysaccharide-induced fulminant hepatic failure in d-galactosamine-sensitized mice. International Immunopharmacology. 10(3). 357–363. 32 indexed citations
20.
Wan, Jingyuan, et al.. (2008). Protective effect of baicalin against Lipopolysaccharide/d-galactosamine-induced liver injury in mice by up-regulation of Heme oxygenase-1. European Journal of Pharmacology. 587(1-3). 302–308. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hamid Mollazadeh Breakdown of academic impact, for papers by Bidya Dhar Sahu Breakdown of academic impact, for papers by Robert Domitrović Breakdown of academic impact, for papers by Jeng‐Shyan Deng Breakdown of academic impact, for papers by Chien‐Chun Li Breakdown of academic impact, for papers by Yanling Zhao Breakdown of academic impact, for papers by Jing‐Hsien Chen Breakdown of academic impact, for papers by Chunhua Ma Breakdown of academic impact, for papers by Yuchen Sheng Breakdown of academic impact, for papers by Hui‐Hsuan Lin
Rankless by CCL
2026